Rock Ventures Iii L.P. Third's Net Worth

Rock Ventures Iii L.P. Third's net worth is estimated to be at least $165,654,131.28 as of 03/04/2024. CoreStreet's estimation of Rock Ventures Iii L.P. Third's net worth is based on their sale of stock and current holding of stock.

Rock Ventures Iii L.P. Third is Major Shareholder at Voyager Therapeutics Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 128,642 units of VYGR stock on 02/01/2023. Their biggest sale was on 01/14/2021 when they sold 1,965,294 units of Relay Therapeutics Inc stock for $80,577,054.00. They typically trade 3 times per year.

Total value of insider buys:
  • $1,090,171.20
Total value of insider sells:
  • $164,563,960.08
Most recent insider trade:
  • Feb. 1, 2023

Rock Ventures Iii L.P. Third's Insider Trading History

Voyager Therapeutics IncTitleAmountPriceTypeTotal Value
Feb. 1, 2023
Major Shareholder128,642$9.32Sell$1,198,943.44
Jan. 30, 2023
Major Shareholder75,000$9.03Sell$677,250.00
Jan. 27, 2023
Major Shareholder50,000$9.02Sell$451,000.00
Jan. 25, 2023
Major Shareholder50,000$9.22Sell$461,000.00
Jan. 23, 2023
Major Shareholder55,000$9.06Sell$498,300.00
Jan. 20, 2023
Major Shareholder100,000$9.15Sell$915,000.00
Aug. 24, 2022
Major Shareholder149,972$6.09Sell$913,329.48
Aug. 15, 2022
Major Shareholder135,808$6.04Sell$820,280.32
Aug. 12, 2022
Major Shareholder348,007$6.12Sell$2,129,802.84
Jounce Therapeutics IncTitleAmountPriceTypeTotal Value
Nov. 12, 2021
Major Shareholder1,900,000$8.38Sell$15,922,000.00
Relay Therapeutics IncTitleAmountPriceTypeTotal Value
Jan. 14, 2021
Major Shareholder1,965,294$41.00Sell$80,577,054.00
Jan. 12, 2021
Major Shareholder1,500,000$40.00Sell$60,000,000.00
Fulcrum Therapeutics IncTitleAmountPriceTypeTotal Value
July 19, 2019
Director61,280$17.79Buy$1,090,171.20